|
ZNF45 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.19930000269864E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.6251444634463E-12 |
| Stage1-vs-Stage2 |
2.128400E-01 |
| Stage1-vs-Stage3 |
8.006000E-02 |
| Stage1-vs-Stage4 |
7.479300E-03 |
| Stage2-vs-Stage3 |
2.193900E-02 |
| Stage2-vs-Stage4 |
4.223200E-03 |
| Stage3-vs-Stage4 |
3.564000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.4663000003079E-07 |
| Normal-vs-Asian |
6.40099973026054E-10 |
| Caucasian-vs-AfricanAmerican |
6.324800E-01 |
| Caucasian-vs-Asian |
4.180600E-01 |
| AfricanAmerican-vs-Asian |
9.044600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62436730732907E-12 |
| Male-vs-Female |
5.970000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.43551837084033E-13 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(81-100Yrs) |
9.962700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.713800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.289600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.617600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.598800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.104600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.474400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.806200E-04 |
| Classical-VS-Follicular |
6.975200E-01 |
| Classical-VS-Other |
6.339400E-01 |
| Classical-VS-Normal |
4.88564744216546E-12 |
| Tall-VS-Follicular |
8.640200E-03 |
| Tall-VS-Other |
4.344800E-01 |
| Tall-VS-Normal |
2.44249065417534E-15 |
| Follicular-VS-Other |
7.888600E-01 |
| Follicular-VS-Normal |
7.22244486439649E-12 |
| Other-VS-Normal |
8.594800E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.4432899320127E-15 |
| N0-vs-N1 |
2.250300E-02 |
|
|
